British pharmaceutical company GlaxoSmithKline is seeking regulatory approval for an antimalarial vaccine. The vaccine is being evaluated by the European Medicines Agencies in collaboration with the World Health Organization (WHO). This could prompt a major global health breakthrough as the disease affects 225 million people worldwide and results in the deaths of approximately 800,000 people, Read More…
In this analysis, Adena Eliasoph explores the heavy burden that non-communicable diseases (NCDs) impose on developing nations, and the extent to which these health issues impinge on the achievement of the Millennium Development Goals (MDGs).
Kyle Chatterson continues his look at the Ebola Viral Fever outbreak ravaging West Africa. In part 3, he reviews the current situation in the affected regions.
Kyle Chatterson examines the impact of the recent Ebola outbreak on western nations, and how the search for treatments is progression.
Jenny Yang’s interview from September 04, 2014 with Lt. Pitcher, who participated in NATO’s ‘Return to Hope’ project, meant to tell the stories of those in Afghanistan.
Piotr Zulauf discusses the concept of the securitization of the HIV/AIDS crisis.
Ben Abonyi explores the nature of the Trans-Pacific Partnership (TPP) trade agreement and its relation to Canada’s generic medicine industry.
In this infographic, Scott Falls defines the Ebola virus, explains the current crisis, and lays out why the 2014 outbreak is so serious.
Carlos Abarca examines the inconsistent population rates across the world and their disparate impacts on future generations.
Ashley Boyes discusses the concept of gender mainstreaming and its benefits for raising awareness of gender issues worldwide.